Clinical Trial Update: A Study of Secukinumab for the Treatment of Alopecia Areata [Phase 2]

View source ↗

Summary

Phase 2 trial of secukinumab for alopecia areata was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Alopecia Areata | Phase 2 | Status: TERMINATED | Results posted: 2017-11-30